Abstract 4499: In vitro and in vivo evaluation of novel Pim kinase inhibitors with potent anticancer activityKrzysztof Brzózka, Nicolas Beuzen, Wojciech Czardybon et al.|Cancer Research|2010Cited by 1
63 Efficacy evaluation of novel Pim kinase inhibitors with anticancer activityKrzysztof Brzózka, Nicolas Beuzen, Renata Windak et al.|European Journal of Cancer Supplements|2010Cited by 0
Abstract B242: Antitumor activity of SEL120: An orally available small-molecule inhibitor of Haspin kinase for standalone and combination therapy with AuroraB inhibitors in colorectal cancer.Tomasz Rzymski, Krzysztof Brzózka, Adrian Zarębski et al.|Molecular Cancer Therapeutics|2011Cited by 0
Abstract A242: Identification of novel and specific Pim-1 kinase inhibitors with potent anticancer activity in hematological and solid tumor malignanciesKrzysztof Brzózka, Nicolas Beuzen, Jan Smagur et al.|Molecular Cancer Therapeutics|2009Cited by 0